RARagnar Asplund

Ragnar Asplund

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ragnar Asplund has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Nocturia in relation to sleep, health, and medical treatment in the elderly

    by Ragnar Asplund

    Nocturia is a common condition in the elderly that profoundly influences general health and quality of life. It appears to predict a higher risk of death. One consequence of nocturia is sleep deterioration, with increased daytime sleepiness and loss of energy and activity. Accidents, e.g. falls, are increased both at night and during the day in elderly persons with nocturia. Nocturia is caused by nocturnal polyuria, reduced voided volumes, or a combination of the two. Nocturnal polyuria can be caused by numerous diseases, e.g. diabetes insipidus, diabetes mellitus, congestive heart failure, and sleep apnoea. A disorder of the vasopressin system, with very low or undetectable vasopressin levels at night, is manifested as an increased nocturnal urine output, which in the most extreme cases reaches 85% of the 24‐h diuresis: the prevalence of low or undetectable vasopressin levels at night has been estimated to be 3–4% in those aged ≥ 65 years. Treatment of nocturia may include avoiding excessive fluid intake and use of diuretic medication in the afternoon rather than the morning, oral desmopressin at bedtime in cases of nocturnal polyuria, and antimuscarinic agents in the case of overactive bladder or impaired storage capacity of the bladder.


  • Locus of control and regional differences in sickness absence in Sweden

    by John Selander, Sven-Uno Marnetoft, Bengt Åkerström, Ragnar Asplund

    The aim of this study was to investigate if there are differences in locus of control (LOC), at a societal level, between two residential areas in Sweden with substantial differences in sickness absence. A postal questionnaire was sent to 1500 randomly selected men and women aged 20 - 64 years. Five hundred questionnaires were sent to people living in Stromsund (a sparsely populated municipality in northern Sweden with high rates of sickness absence) and 1000 questionnaires to people in the Swedish capital of Stockholm, which has a low rate of sickness absence. A comparison of LOC in the two study areas supported our hypothesis to a certain extent, external locus being more prominent in Stromsund. When physical and mental health and income were considered, however, the differences disappeared. Consequently, this study did not support the opinion that differences in sickness absence can be explained by LOC at a societal level.


  • Nocturia in relation to somatic health, mental health and pain in adult men and women

    by Ragnar Asplund, Sven‐Uno Marnetoft, John Selander, Bengt Åkerström

    OBJECTIVE: To assess the relationship of nocturia to somatic health, mental health and bodily pain. SUBJECTS AND METHODS: A randomly selected group of men and women aged 20–64 years, living in three small municipalities in northern Sweden, or in the city of Östersund or in Stockholm, were sent a postal questionnaire containing questions on somatic and mental health, satisfaction with life, pain, nocturnal voiding, work and sick‐listing from work. RESULTS: Reports (from 1948 respondents) on poor somatic and mental health and on pain all increased in parallel with increasing frequency of nocturnal voids. In a multiple logistic regression analysis with sex, age, somatic health, mental health and bodily pain as the independent variables, significant independent correlates (odds ratios, confidence intervals) of nocturnal micturition (two or more episodes vs none or one) were: age 45–59 vs 20–44 years, 1.9 (1.3–2.7), ≥60 vs 20–44 years, 3.8 (2.4–6.0); somatic health, poor vs good, 2.3 (1.4–3.7); mental health, poor vs good, 1.9 (1.2–3.0); pain, rather mild vs very mild or none, 1.5 (1.0–2.3); rather severe vs very mild or none, 1.9 (1.1–3.2); and very severe vs very mild or none, 6.0 (2.5–14.0). Gender was deleted by the logistic model. Sick‐listing for ≥ 60 days during the past year was reported by 4.9%, 10.6%, 5.6% and 38.9% of the men with none, one, two or ≥ three nocturnal voids, respectively, and by 10%, 12.4%, 23% and 46.7% (both P < 0.001) of the corresponding women, respectively. Life satisfaction decreased in parallel with increased nocturia. CONCLUSION: The impairment of both somatic and mental health was associated with increased nocturnal voiding. Pain was associated with a substantial increase in nocturia after adjusting for age and somatic and mental health. Sick‐leave was more common in association with more nocturnal voids.


  • Nocturia, depression and antidepressant medication

    by Ragnar Asplund, Susanne Johansson, Svante Henriksson, Göran Isacsson

    OBJECTIVE: To assess the possible relationship between treatment with selective serotonin‐reuptake inhibitors (SSRIs) and the occurrence of nocturia. SUBJECTS AND METHODS: An unselected group of adult men and women, living in the city of Östersund, Sweden, were sent a postal questionnaire containing questions on somatic and mental health, sleep, sleepiness and nocturia. For depression diagnostics, the Major Depression Inventory (MDI) was used. Prescription data on antidepressant drugs were extracted from a register in the county of Jämtland, Sweden. RESULTS: The questionnaire was completed by 1375 subjects, of whom 609 (44%) were men; the response rate was 69%. Prescription data were available for all respondents. The mean ( sd ) age of the men and women participating were 48.0 (18.2) and 50.1 (19.1) years, respectively. Two or more nocturnal micturition episodes were reported in 15.6% of the men and 16.5% of the women. In a multiple logistic regression analysis, independent correlates for two or more nocturnal voids vs no more than one were: age 45–59 years vs <45 (odds ratio 2.9; 95% confidence interval 1.9–4.7); age 60–74 vs 75 vs <45 (13.4; 7.9–22.6); major depression, yes vs no (4.6; 2.8–7.5); and being on treatment with SSRI, yes vs no (2.2; 1.1–4.5). Gender was deleted by the logistic regression model. CONCLUSION: Major depression has previously been found to be associated with increased nocturnal micturition. In the present study, twice as many men and women treated with SSRIs as those not so treated had two or more nocturnal voids, after adjusting for major depression and age. The implication for the risk of fall injuries is discussed.


  • Oral dryness, nocturia and the menopause

    by Ragnar Asplund, Hans Edvard Åberg


  • Nocturia and depression

    by R. Asplund, S. Henriksson, S. Johansson, G. Isacsson

    OBJECTIVE: To assess the possible relationship between major depression (MD) and nocturia. SUBJECTS AND METHODS: An unselected group of adult men and women, living in the city of Östersund, Sweden, were sent a postal questionnaire containing questions on somatic and mental health, sleep, sleepiness and nocturia. For depression diagnostics the Major Depression Inventory (MDI) was used. RESULTS: The mean ( sd ) ages of the men and women were 48.0 (18.2) and 50.1 (19.1) years, respectively. Two or more nocturnal micturition episodes occurred in 15.6% of the men and 16.5% of the women. In a multiple logistic regression analysis independent correlates (with 95% confidence intervals) for ≥ 2 nocturnal voids in men were: MD 6.5 (2.6–15.6); health, fair vs good, 1.8 (1.0–3.9); health, poor vs good, 2.7 (1.1–4.8); age, 60–74 vs 18–29, 3.6 (1.5–8.4) and age ≥ 75 vs 18–29 6.7 (2.6–17.4); and in women: MD 2.8 (1.3–6.3); health, fair vs good, 1.9 (1.1–3.2); health, poor vs good, 4.3 (2.6–8.2); age, 60–74 vs 18–29, 3.8 (1.8–7.8), and age ≥ 75 vs 18–29, 8.6 (4.0–18.6). Age < 60 years was deleted by the logistic model in both sexes. CONCLUSION: MD is associated with a six‐fold increase in nocturia in men and a three‐fold increase in women, after accounting for age and health. Possible pathogenetic mechanisms of this relationship may involve both increased nocturnal diuresis via a disturbed 24‐h rhythm of antidiuretic hormone secretion, and a decrease in nocturnal bladder capacity through a central and/or peripheral serotonergic effect.